A Phase II, Randomised, Double-Blind, Placebo-Controlled, Parallel Group Study to Assess the Effect of AZD0780 in Combination With Rosuvastatin on Low Density Lipoprotein Cholesterol in Participants With Dyslipidaemia (LAZURE)
Latest Information Update: 26 Oct 2025
At a glance
- Drugs Laroprovstat (Primary) ; Rosuvastatin
- Indications Hyperlipidaemia
- Focus Therapeutic Use
- Acronyms LAZURE
- Sponsors AstraZeneca
Most Recent Events
- 26 Oct 2025 New trial record